MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash
$5,106,872
Other prepaid
expenses
$44,825
Prepaid insurance
$26,682
Light proton therapy
system equipment
$6,582,560
Total current assets
$5,178,379
Right-of-use lease assets
$972,682
Total assets
$12,733,621
Total liabilities and
stockholders equity
$12,733,621
Total stockholders
equity
$10,961,551
Total liabilities
$1,772,070
Total lixte
biotechnology stockholders...
$9,664,059
Non-controlling interest
$1,297,492
Total current
liabilities
$1,333,111
Operating lease
obligations, long-term
$438,959
Accumulated deficit
-$58,077,213
Additional paid-in capital
$66,008,824
Operating lease
obligations, current
$595,418
Related parties
accounts payable and...
$436,482
Research and development
contract liabilities
$232,138
Series b convertible
preferred stock 8...
$69,073
Preferred stock, value
$1,731,569
Common stock, 0.0001
par value...
$879
Back
Back
Balance Sheet
source: myfinsight.com
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)